α-Capecitabine

α-Capecitabine Struktur
2230479-30-6
CAS-Nr.
2230479-30-6
Englisch Name:
α-Capecitabine
Synonyma:
2(1H)-Pyrimidinone, 4-amino-1-(2,3-di-O-acetyl-5-deoxy-α-D-ribofuranosyl)-5-fluoro-;Capecitabine impurity 5/(2S,3R,4R,5R)-2-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate
CBNumber:
CB45431878
Summenformel:
C13H16FN3O6
Molgewicht:
329.28
MOL-Datei:
2230479-30-6.mol

α-Capecitabine Eigenschaften

Siedepunkt:
427.4±55.0 °C(Predicted)
Dichte
1.57±0.1 g/cm3(Predicted)
pka
2.49±0.10(Predicted)

Sicherheit

α-Capecitabine Chemische Eigenschaften,Einsatz,Produktion Methoden

α-Capecitabine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


α-Capecitabine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11922 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9906 50
Lianyungang TengFa Biological Technology Co. Ltd 0518-85475186 18705131893
wang666xt@163.com China 351 55
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@yongstandards.com China 10001 55
Jiangsu Wansipu Technology Co., Ltd. 17826022701
1485609990@qq.com China 999 58
QUALITY CONTROL SOLUTIONS LTD. +86-0755-66853366 +86-13670046396
export03@qcsrm.com China 24342 58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd 0714-5316360; 13165688766
3008058303@qq.com China 3000 58
Hubei Yangxin Medical Technology Co., Ltd. 0714-3299675 13092790750
3003355938@qq.com China 9978 58
Shanghai meikai technology co., ltd 021-68689288 15300790979
info@mkbio.com.cn China 5000 58

  • Capecitabine impurity 5/(2S,3R,4R,5R)-2-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate
  • 2(1H)-Pyrimidinone, 4-amino-1-(2,3-di-O-acetyl-5-deoxy-α-D-ribofuranosyl)-5-fluoro-
  • 2230479-30-6
Copyright 2019 © ChemicalBook. All rights reserved